http://www.echemstore.com/st072188-hydroxychloroquine-sulfate.html http://www.echemstore.com/index.php/catalog/product/view/id/86240 http://www.echemstore.com/st028786-carbutamide.html

Potent Tumor Necrosis Factor Alpha Inducers


The screen of TimTec compounds identified 6 potent TNF-alpha inducers, which are available from our stock.

Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production. Schepetkin IA, Kirpotina LN, Tian J, Khlebnikov AI, Ye RD, Quinn MT. Mol Pharmacol. 2008 Aug;74(2):392-402.

 

Abstract

Development of immunomodulatory agents that enhance innate immune responses represents a promising strategy for combating infectious diseases. In the present studies, we screened a series of 71 arylcarboxylic acid hydrazide derivatives for their ability to induce macrophage tumor necrosis factor a (TNF-alpha) production and identified 6 such compounds, including one compound previously shown to be a formyl peptide receptor (FPR/FPRL1) agonist. The two most potent compounds [Compound 1: nicotinic acid [5-(3-bromophenyl)-2-furyl]methylene-hydrazide; Compound 2:4-fluoro-benzoic acid [5-(3-trifluoromethyl-phenyl)-2-furyl]methylene-hydrazide] were selected for further analysis. These compounds induced denovo production of TNF-alpha in a dose- and time-dependent manner in human and murine monocyte/macrophage cell lines and in primary macrophages. These compounds also induced mobilization of intracellular Ca2+, production of reactive oxygen species, and chemotaxis in human and murine phagocytes.Induction of macrophage TNF-alpha production was pertussis toxinsensitive, and analysis of the cellular target of these compounds showed that they were FPRL1-specific agonists and that this response was blocked byFPR/FPRL1 and FPRL1-specific antagonists. Additionally, pharmacophore modeling showed a high degree of similarity for lowenergy conformations of these two compounds to the current pharmacophore model for FPR ligands (Edwards et al., 2005 Overall, these compounds represent novel FPRL1 agonists that induce TNF-alpha, a response distinct from those induced by other known FPR and FPRL1 agonists.

Chemical structures of the most potent TNF-alpha inducers

 

 

 

ST013006

MW 370.21

MF C17H12BrN3O2

N-{(1E)-2-[5-(3-bromophenyl)(2-furyl)]-1-azavinyl}-3-pyridylcarboxamide

ST013006

ST020452

MW 376.31

MF C19H12F4N2O2

N-((1Z)-2-{5-[3-(trifluoromethyl)phenyl](2-furyl)}-1-azavinyl)(4-fluorophenyl) carboxamide

ST020452
ST020520

MW 404.42

MF C23H20N2O5

2H-benzo[3,4-d]1,3-dioxolan-5-yl-N-{(1Z)-2-[3-methoxy-4-(phenylmethoxy)phenyl] -1-azavinyl}carboxamide

ST020520

ST020527

MW 359.21

MF C18H12Cl2N2O2

N-{(1E)-2-[5-(2,3-dichlorophenyl)(2-furyl)]-1-azavinyl}benzamide

ST020527

ST041063

MW 413.77

MF C19H12ClN3O6

2H-benzo[3,4-d]1,3-dioxolan-5-yl-N-{(1Z)-2-[5-(2-chloro-4-nitrophenyl)(2-furyl )]-1-azavinyl}carboxamide

ST041063

ST073755

MW 312.328

MF C16H16N4O3

N-{(1E)-2-[4-(dimethylamino)phenyl]-1-azavinyl}(4-nitrophenyl)carboxamide

ST073755

BioActive Scroller

ST096084 Nateglinide

ST096084 Nateglinide

Formula: C19H27NO3MW: 317.43CAS: 105816-04-4MDL NUMBER: MFCD00875706Smiles: CC(C)C1CCC(CC1)C(=O)NC(C..
ST096085 Flupirtine maleate

ST096085 Flupirtine maleate

Formula: C19H21FN4O6MW: 420.4CAS: 75507-68-5MDL NUMBER: MFCD00941415Smiles: OC(=O)/C=C/C(O)=O.CCOC(=..
ST096086 Flibanserin

ST096086 Flibanserin

Formula: C20H21F3N4OMW: 390.41CAS: 167933-07-5MDL NUMBER: MFCD00918402Smiles: FC(F)(F)c1ccc(cc1)N1CC..